1.18
price down icon10.61%   -0.14
after-market Dopo l'orario di chiusura: 1.18
loading
Precedente Chiudi:
$1.32
Aprire:
$1.25
Volume 24 ore:
881
Relative Volume:
0.01
Capitalizzazione di mercato:
$1.97M
Reddito:
$2.00M
Utile/perdita netta:
$-50.62M
Rapporto P/E:
-0.0282
EPS:
-41.8255
Flusso di cassa netto:
$-37.11M
1 W Prestazione:
-4.84%
1M Prestazione:
-65.99%
6M Prestazione:
-86.29%
1 anno Prestazione:
-96.47%
Intervallo 1D:
Value
$1.18
$1.28
Intervallo di 1 settimana:
Value
$1.18
$1.32
Portata 52W:
Value
$1.07
$71.50

Bioatla Inc Stock (BCAB) Company Profile

Name
Nome
Bioatla Inc
Name
Telefono
858-558-0708
Name
Indirizzo
11085 TORREYANA ROAD, SAN DIEGO
Name
Dipendente
41
Name
Cinguettio
Name
Prossima data di guadagno
2026-08-13
Name
Ultimi documenti SEC
Name
BCAB's Discussions on Twitter

Compare BCAB vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
BCAB icon
BCAB
Bioatla Inc
1.18 5.30M 2.00M -50.62M -37.11M -41.83
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
514.56 132.08B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
793.26 83.15B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
984.04 62.71B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
136.62 54.14B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
203.35 44.51B 742.00K -1.37B -1.07B -7.0731

Bioatla Inc Stock (BCAB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-01-13 Iniziato Rodman & Renshaw Buy
2025-08-13 Downgrade Citizens JMP Mkt Outperform → Mkt Perform
2024-11-13 Downgrade H.C. Wainwright Buy → Neutral
2022-09-15 Iniziato JMP Securities Mkt Outperform
2022-05-05 Downgrade Credit Suisse Outperform → Neutral
2022-03-21 Iniziato H.C. Wainwright Buy
2021-10-15 Ripresa BTIG Research Buy
2021-06-28 Iniziato ROTH Capital Buy
2021-05-05 Ripresa Credit Suisse Outperform
2021-04-26 Ripresa Credit Suisse Outperform
2021-01-11 Iniziato BTIG Research Buy
2021-01-11 Iniziato Credit Suisse Outperform
2021-01-11 Iniziato JP Morgan Overweight
2021-01-11 Iniziato Jefferies Buy
Mostra tutto

Bioatla Inc Borsa (BCAB) Ultime notizie

pulisher
Sep 08, 2026

Bioatla Inc (NYSE: BCAB) Share Price, BCAB Stock News, BCAB Share Price & Updates - Kalkine

Sep 08, 2026
pulisher
Sep 05, 2026

Bioatla Stock Price Forecast. Should You Buy BCAB? - StockInvest.us

Sep 05, 2026
pulisher
Sep 02, 2026

BioAtla (BCAB) CMO has RSU shares withheld for taxes - Stock Titan

Sep 02, 2026
pulisher
Sep 02, 2026

BioAtla (BCAB) CEO still holds 52,035 shares after tax withholding - Stock Titan

Sep 02, 2026
pulisher
Sep 02, 2026

BioAtla (BCAB) CFO’s stock move is a tax withholding, not a sale - Stock Titan

Sep 02, 2026
pulisher
Sep 02, 2026

BioAtla, Inc. Financial Disclosures & SEC Filings - TradingView

Sep 02, 2026
pulisher
Sep 02, 2026

Book value per share of BioAtla, Inc. – OTC:BCAB - TradingView

Sep 02, 2026
pulisher
Sep 02, 2026

BioAtla, Inc. Actuals & Estimates (OTC:BCAB) - TradingView

Sep 02, 2026
pulisher
Sep 01, 2026

BioAtla, Inc.(NasdaqCM: BCAB) dropped from S&P TMI Index - marketscreener.com

Sep 01, 2026
pulisher
Sep 01, 2026

Return on invested capital % of BioAtla, Inc. – OTC:BCAB - TradingView

Sep 01, 2026
pulisher
Sep 01, 2026

Enterprise value of BioAtla, Inc. – OTC:BCAB - TradingView

Sep 01, 2026
pulisher
Aug 31, 2026

Diluted shares outstanding of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Net current asset value per share of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Price to cash flow ratio of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Enterprise value to EBIT forward of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Enterprise value to EBITDA forward of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Enterprise value to revenue forward of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Enterprise value to EBITDA ratio of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

EBITDA margin % of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Cost of goods sold of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Operating expenses (excl. COGS) of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Operating income of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Diluted earnings per share (diluted EPS) of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

After tax other income/expense of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Cash flow from investing activities of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Cash flow from operating activities of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Average basic shares outstanding of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Free cash flow of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Non-controlling/minority interest of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Total revenue of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Cash flow from financing activities of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Gross profit of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

EBITDA of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Net income before discontinued operations of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Dilution adjustment of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Non-operating income (total) of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Total debt of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

BioAtla, Inc. Cash Flow – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Total equity of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Net debt of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

BioAtla, Inc. Statistics – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

BioAtla, Inc. Balance Sheet – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

BioAtla, Inc. Earnings and Revenue – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

BioAtla, Inc. Revenue Breakdown – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Net income of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

BioAtla, Inc. Financial Statements – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

ETFs Investing in BioAtla, Inc. Stocks - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

BioAtla, Inc. Income Statement – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Free float of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Price to earnings ratio of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026
pulisher
Aug 31, 2026

Basic earnings per share (basic EPS) of BioAtla, Inc. – OTC:BCAB - TradingView

Aug 31, 2026

Bioatla Inc Azioni (BCAB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$58.75
price down icon 3.04%
$127.28
price down icon 1.18%
$40.94
price down icon 2.08%
$247.51
price down icon 4.07%
ONC ONC
$341.80
price down icon 2.62%
$203.35
price down icon 2.08%
Capitalizzazione:     |  Volume (24 ore):